Arklow is a technology company.
Arklow has raised $50K across 1 funding round.
Arklow has raised $50K in total across 1 funding round.
Arklow has raised $50K in total across 1 funding round.
Arklow's investors include Cometa, Hustle Fund, Magma Partners, MYASIAVC PTE LTD, Parade Ventures, Claire Diaz-Ortiz.
No technology company named Arklow exists based on available information. Arklow primarily refers to a coastal town in County Wicklow, Ireland, known for industrial facilities rather than a standalone tech firm.[1][3] The most prominent "Arklow" entity in a tech-adjacent context is the former SAFC Arklow facility (now Merck Life Science), a 64,000 m² cGMP manufacturing site for commercial and late-stage active pharmaceutical ingredients (APIs) and advanced intermediates, specializing in contract manufacturing with capabilities like alkylation, esterification, and large-scale simulated moving bed chromatography.[3] This site, a subsidiary operation of Merck KGaA (via Sigma-Aldrich/MilliporeSigma), served pharmaceutical clients by producing high-purity excipients, solvents, and custom APIs under ICH Q7 and FDA standards, but Merck announced its closure by end-2028, impacting up to 100 jobs after a strategic portfolio review.[1][3]
A separate, emerging entity called Arklow appears in startup directories as a Lithuania-based company focused on compliance tools for AI models and datasets, though details on products, customers, or traction are limited.[5] Other mentions include Arklow Shipping (a 1966-founded maritime firm with 59 vessels using VSAT satellite tech for operations)[2] and generic software services in Arklow town,[4] but none match a prominent technology company profile.
The Merck Arklow facility evolved from SAFC (Sigma-Aldrich Fine Chemicals), established as a key hub for API production in Ireland, with expertise in process development, validation, and technology transfer for pharma clients.[3] It featured specialized equipment like 500L stainless steel filter dryers and vacuum tray ovens, supporting core chemistries and analytical services inspected by FDA and HPRA.[3] Operations faced recent headwinds, with Merck's 2028 closure decision following market dynamics and customer needs reviews, despite prior €440m investments in Irish sites like Carrigtwohill.[1]
The AI compliance startup "Arklow" lacks detailed founding info but is listed in Lithuanian startup maps, implying recent emergence in the AI governance space.[5] Arklow town itself has hosted diverse projects, from a €139m wastewater plant (operational 2024, aiding sustainable infrastructure)[6] to planned data centers leveraging proximity to Dublin.[7]
For the Merck Arklow facility (pharma manufacturing, not pure tech):
For the AI Arklow startup:
Arklow Shipping differentiates via fleet-scale adoption of Aura VSAT and Intellian systems for reliable maritime comms, but it's logistics-focused.[2]
Arklow entities intersect tech peripherally: the Merck facility rode biopharma manufacturing trends, enabling advanced therapies like vaccines and gene modalities via precise API production, though closure reflects consolidating market dynamics favoring larger sites like Carrigtwohill.[1][3] The AI Arklow taps AI regulation waves (e.g., EU AI Act), where compliance tools are critical amid rising scrutiny of models/datasets—timing aligns with 2024-2025 enforcement ramps.[5] Infrastructure in Arklow town supports tech growth, with data center plans harnessing Ireland's connectivity and the wastewater plant as a sustainability model unlocking development.[6][7] Overall, Arklow influences via industrial enablers rather than core innovation, amid Ireland's pharma/tech hub status.
Merck's Arklow winds down by 2028, shifting focus to expanded Irish sites—expect job transitions and portfolio migration, underscoring CDMO consolidation.[1] The AI Arklow could scale if AI regs tighten, riding trends like automated auditing and dataset provenance. Data centers may boost Arklow as an edge computing node near Dublin.[7] Watch for redevelopments post-closure, potentially pivoting pharma tech to data/AI infrastructure, tying back to Arklow's evolution from industrial base to potential tech adjunct.
Arklow has raised $50K across 1 funding round. Most recently, it raised $50K Seed in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2022 | $50K Seed | Cometa, Hustle Fund, Magma Partners, MYASIAVC PTE LTD, Parade Ventures, Claire Diaz-Ortiz |